592 related articles for article (PubMed ID: 26240142)
1. Enhanced transfer of a photocross-linking N-acetylglucosamine (GlcNAc) analog by an O-GlcNAc transferase mutant with converted substrate specificity.
Rodriguez AC; Yu SH; Li B; Zegzouti H; Kohler JJ
J Biol Chem; 2015 Sep; 290(37):22638-48. PubMed ID: 26240142
[TBL] [Abstract][Full Text] [Related]
2. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
[TBL] [Abstract][Full Text] [Related]
3. Catalytic Promiscuity of O-GlcNAc Transferase Enables Unexpected Metabolic Engineering of Cytoplasmic Proteins with 2-Azido-2-deoxy-glucose.
Shen DL; Liu TW; Zandberg W; Clark T; Eskandari R; Alteen MG; Tan HY; Zhu Y; Cecioni S; Vocadlo D
ACS Chem Biol; 2017 Jan; 12(1):206-213. PubMed ID: 27935279
[TBL] [Abstract][Full Text] [Related]
4. New ELISA-based method for the detection of O-GlcNAc transferase activity in vitro.
Qi J; Wang R; Zeng Y; Yu W; Gu Y
Prep Biochem Biotechnol; 2017 Aug; 47(7):699-702. PubMed ID: 28296566
[TBL] [Abstract][Full Text] [Related]
5. Substrate and product analogues as human O-GlcNAc transferase inhibitors.
Dorfmueller HC; Borodkin VS; Blair DE; Pathak S; Navratilova I; van Aalten DM
Amino Acids; 2011 Mar; 40(3):781-92. PubMed ID: 20640461
[TBL] [Abstract][Full Text] [Related]
6. Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates.
Shen DL; Gloster TM; Yuzwa SA; Vocadlo DJ
J Biol Chem; 2012 May; 287(19):15395-408. PubMed ID: 22311971
[TBL] [Abstract][Full Text] [Related]
7. Substrate specificity provides insights into the sugar donor recognition mechanism of O-GlcNAc transferase (OGT).
Ma X; Liu P; Yan H; Sun H; Liu X; Zhou F; Li L; Chen Y; Muthana MM; Chen X; Wang PG; Zhang L
PLoS One; 2013; 8(5):e63452. PubMed ID: 23700425
[TBL] [Abstract][Full Text] [Related]
8. Potential regulation of nuclear UDP-N-acetylglucosaminyl transferase (OGT) by substrate availability: ability of chromatin protein to bind UDP-N-acetylglucosamine and reduce OGT-mediated O-Linked glycosylation.
Okuyama R; Marshall S
Biol Pharm Bull; 2004 Aug; 27(8):1293-6. PubMed ID: 15305040
[TBL] [Abstract][Full Text] [Related]
9. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
[TBL] [Abstract][Full Text] [Related]
10. The conserved threonine-rich region of the HCF-1
Kapuria V; Röhrig UF; Waridel P; Lammers F; Borodkin VS; van Aalten DMF; Zoete V; Herr W
J Biol Chem; 2018 Nov; 293(46):17754-17768. PubMed ID: 30224358
[No Abstract] [Full Text] [Related]
11.
Selvan N; George S; Serajee FJ; Shaw M; Hobson L; Kalscheuer V; Prasad N; Levy SE; Taylor J; Aftimos S; Schwartz CE; Huq AM; Gecz J; Wells L
J Biol Chem; 2018 Jul; 293(27):10810-10824. PubMed ID: 29769320
[TBL] [Abstract][Full Text] [Related]
12. Targeting O-glycosyltransferase (OGT) to promote healing of diabetic skin wounds.
Runager K; Bektas M; Berkowitz P; Rubenstein DS
J Biol Chem; 2014 Feb; 289(9):5462-6. PubMed ID: 24398691
[TBL] [Abstract][Full Text] [Related]
13. Direct One-Step Fluorescent Labeling of O-GlcNAc-Modified Proteins in Live Cells Using Metabolic Intermediates.
Tan HY; Eskandari R; Shen D; Zhu Y; Liu TW; Willems LI; Alteen MG; Madden Z; Vocadlo DJ
J Am Chem Soc; 2018 Nov; 140(45):15300-15308. PubMed ID: 30296064
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.
Isono T
PLoS One; 2011 Apr; 6(4):e18959. PubMed ID: 21526146
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a missense mutation in the
Vaidyanathan K; Niranjan T; Selvan N; Teo CF; May M; Patel S; Weatherly B; Skinner C; Opitz J; Carey J; Viskochil D; Gecz J; Shaw M; Peng Y; Alexov E; Wang T; Schwartz C; Wells L
J Biol Chem; 2017 May; 292(21):8948-8963. PubMed ID: 28302723
[No Abstract] [Full Text] [Related]
16. Mutations in
Willems AP; Gundogdu M; Kempers MJE; Giltay JC; Pfundt R; Elferink M; Loza BF; Fuijkschot J; Ferenbach AT; van Gassen KLI; van Aalten DMF; Lefeber DJ
J Biol Chem; 2017 Jul; 292(30):12621-12631. PubMed ID: 28584052
[No Abstract] [Full Text] [Related]
17. O-GlcNAcylation regulates β1,4-GlcNAc-branched N-glycan biosynthesis via the OGT/SLC35A3/GnT-IV axis.
Song W; Isaji T; Nakano M; Liang C; Fukuda T; Gu J
FASEB J; 2022 Feb; 36(2):e22149. PubMed ID: 34981577
[TBL] [Abstract][Full Text] [Related]
18. Metabolic labeling enables selective photocrosslinking of O-GlcNAc-modified proteins to their binding partners.
Yu SH; Boyce M; Wands AM; Bond MR; Bertozzi CR; Kohler JJ
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4834-9. PubMed ID: 22411826
[TBL] [Abstract][Full Text] [Related]
19. Elucidating the protein substrate recognition of O-GlcNAc transferase (OGT) toward O-GlcNAcase (OGA) using a GlcNAc electrophilic probe.
Kositzke A; Fan D; Wang A; Li H; Worth M; Jiang J
Int J Biol Macromol; 2021 Feb; 169():51-59. PubMed ID: 33333092
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK).
Bullen JW; Balsbaugh JL; Chanda D; Shabanowitz J; Hunt DF; Neumann D; Hart GW
J Biol Chem; 2014 Apr; 289(15):10592-10606. PubMed ID: 24563466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
